These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31359391)
1. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN. Jurutka PW; Wagner CE Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391 [TBL] [Abstract][Full Text] [Related]
2. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN. Wagner CE; Jurutka PW Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392 [TBL] [Abstract][Full Text] [Related]
3. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852 [TBL] [Abstract][Full Text] [Related]
4. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN). Heck MC; Wagner CE; Shahani PH; MacNeill M; Grozic A; Darwaiz T; Shimabuku M; Deans DG; Robinson NM; Salama SH; Ziller JW; Ma N; van der Vaart A; Marshall PA; Jurutka PW J Med Chem; 2016 Oct; 59(19):8924-8940. PubMed ID: 27592633 [TBL] [Abstract][Full Text] [Related]
5. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB). Jurutka PW; di Martino O; Reshi S; Mallick S; Sabir ZL; Staniszewski LJP; Warda A; Maiorella EL; Minasian A; Davidson J; Ibrahim SJ; Raban S; Haddad D; Khamisi M; Suban SL; Dawson BJ; Candia R; Ziller JW; Lee MY; Liu C; Liu W; Marshall PA; Welch JS; Wagner CE Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830251 [TBL] [Abstract][Full Text] [Related]
6. Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254). Jurutka PW; Kaneko I; Yang J; Bhogal JS; Swierski JC; Tabacaru CR; Montano LA; Huynh CC; Jama RA; Mahelona RD; Sarnowski JT; Marcus LM; Quezada A; Lemming B; Tedesco MA; Fischer AJ; Mohamed SA; Ziller JW; Ma N; Gray GM; van der Vaart A; Marshall PA; Wagner CE J Med Chem; 2013 Nov; 56(21):8432-54. PubMed ID: 24180745 [TBL] [Abstract][Full Text] [Related]
7. Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner. Pettersson F; Hanna N; Lagodich M; Dupéré-Richer D; Couture MC; Choi C; Miller WH J Biol Chem; 2008 Aug; 283(32):21945-52. PubMed ID: 18544536 [TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox. Gorgun G; Foss F Blood; 2002 Aug; 100(4):1399-403. PubMed ID: 12149223 [TBL] [Abstract][Full Text] [Related]
9. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas. Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW Cells; 2023 Nov; 12(21):. PubMed ID: 37947652 [TBL] [Abstract][Full Text] [Related]
10. Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention. Zhang D; Leal AS; Carapellucci S; Shahani PH; Bhogal JS; Ibrahim S; Raban S; Jurutka PW; Marshall PA; Sporn MB; Wagner CE; Liby KT Cancer Prev Res (Phila); 2019 Apr; 12(4):211-224. PubMed ID: 30760500 [TBL] [Abstract][Full Text] [Related]
11. Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics. Melo N; Belyaeva OV; Berger WK; Halasz L; Yu J; Pilli N; Yang Z; Klyuyeva AV; Elmets CA; Atigadda V; Muccio DD; Kane MA; Nagy L; Kedishvili NY; Renfrow MB J Biol Chem; 2023 Jan; 299(1):102746. PubMed ID: 36436565 [TBL] [Abstract][Full Text] [Related]
12. Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene). Wagner CE; Jurutka PW; Marshall PA; Groy TL; van der Vaart A; Ziller JW; Furmick JK; Graeber ME; Matro E; Miguel BV; Tran IT; Kwon J; Tedeschi JN; Moosavi S; Danishyar A; Philp JS; Khamees RO; Jackson JN; Grupe DK; Badshah SL; Hart JW J Med Chem; 2009 Oct; 52(19):5950-66. PubMed ID: 19791803 [TBL] [Abstract][Full Text] [Related]
13. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene. Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071 [TBL] [Abstract][Full Text] [Related]
16. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain. Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139 [TBL] [Abstract][Full Text] [Related]
17. The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha/beta-dual agonist). Takamatsu K; Takano A; Yakushiji N; Morohashi K; Morishita K; Matsuura N; Makishima M; Tai A; Sasaki K; Kakuta H ChemMedChem; 2008 May; 3(5):780-7. PubMed ID: 18297677 [TBL] [Abstract][Full Text] [Related]
18. Modulation of RXR function through ligand design. Pérez E; Bourguet W; Gronemeyer H; de Lera AR Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403 [TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents. Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]